Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Deerfield Newsletter – Why Genetics Matters in Tackling Covid-19, Research Bites, Licensing IP from State Universities, Break into the Boardroom Bios, Deerfield Foundation
Challenges Inherent in Healthcare, Deerfield in the News, Coronavirus & Preventing Future Viral Epidemics, Research Bites, IP Corner, Break into the Boardroom, Captured our Interest, Deerfield Foundation
Shifting Care to the Home, Research Bites, IP Corner, Break into the Boardroom Bios, Captured our Interest, Deerfielders Trade Spreadsheets for Hammers, Deerfield CEO Conference Storms South Carolina
InFocus/Genomics: How Next Generation Sequencing Might Play Out and the Implications for Precision Medicine, Deerfield in the News, Deerfield Research Bites, IP Corner, Break Into The Boardroom: BIB Bios, Captured Our Interest, Deerfield Foundation, Meet The Associates
States Start To Take The Reins On New Payment Schemes, Breaking Into The Boardroom Speaker Rallies Women At Annual Meeting To Play Nice, IP Corner, Peer-Reviewed Abstracts, News You May Have Missed, Caught Our Eye, Deerfield Foundation, Meet The Associates
Revisiting Biosimilars: A Closer Look at the Commercial Barriers, New and Noteworthy Approvals from 2018, Peer-Reviewed Abstracts, IP Corner, Caught Our Eye, Deerfield Foundation, News You May Have Missed, Meet the Associates, Deerfield Employees Volunteer for Habitat for Humanity
Inaugural Approvals for RNA-Based Medicine, New Story Reignites Old Debate on Conflict of Interest, Peer-Reviewed Abstracts, IP Corner, Caught Our Eye, Deerfield Foundation, News You May Have Missed, News From Our Foundation Partners, Meet the Associates
We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site, you are agreeing to our use of cookies.Allow CookiesDeclinePrivacy policy